Ziopharm Oncology (ZIOP) Has No Plans to Access Capital Markets
Tweet Send to a Friend
ZIOPHARM Oncology, Inc. (Nasdaq: ZIOP), due to recent developments, today issued the following statement clarifying market speculation ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE